Stem Cell Therapeutic and Research Reauthorization Act of 2026

Hozzl · 2026-04-01T14:10:13Z

Explore the details of Senate Bill 4109 Stem Cell Therapeutic and Research Reauthorization Act of 2026 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

4/1/2026, 2:10 PM

Summary of Bill S 4109

This bill, titled "A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes," was introduced in the 119th Congress on March 17, 2026. The bill aims to renew the Stem Cell Therapeutic and Research Act of 2005, suggesting a continuation or potential update of existing legislation in the field of stem cell research and therapy. Specific provisions and additional directives are not provided in the context.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 4109

Bill S 4109 is currently in the status of Bill Introduced since March 17, 2026. Bill S 4109 was introduced during Congress 119 and was introduced to the Senate on March 17, 2026. Bill S 4109's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093) as of March 17, 2026

Bipartisan Support of Bill S 4109

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 4109

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4109

Stem Cell Therapeutic and Research Reauthorization Act of 2026

A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Comments

Naya McIntosh

625

20 days ago

I'm not in favor of this bill. It could potentially impact the availability of stem cell therapies that could benefit many individuals, including myself.